ULTRA-TEST 200 (CYP 80%/PROP 20%) 200MG/ML INJECTABLE 1 ML 10 ML 10 MLS 12 ML 15 ML 18 ML 2 ML 20 ML 20 MLS…
Medicine recall D-1636-2012. Published in FDA’s Enforcement Report on Aug 22, 2012.
No Watch here, and no alerts: openFDA asks that its enforcement data “should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall” (openFDA). For FDA’s own recall emails, subscribe at FDA. FDA’s own record is on accessdata.fda.gov.
The short answer
Published in FDA’s Enforcement Report on Aug 22, 2012. Copied from openFDA on Oct 20, 2026.
- Class II FDA’s class
- Terminated its status, in FDA’s file
- Nationwide FDA’s word for where it went
- 1193 units how much, in FDA’s words
Every line below is in FDA’s own words, with its source beside it. FDA’s terms are explained in FDA’s own words.
How serious is it, by FDA’s class?
Class II, the middle of FDA’s three classes.
“Products that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.”
openFDA, in plain words, its enforcement report fields.
“Class II is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
FDA’s rule, 21 CFR 7.3(m)(2), eCFR.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
What’s wrong with it?
Lack of Assurance of Sterility: Franck’s Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
FDA, Drug recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Which ones are recalled?
ULTRA-TEST 200 (CYP 80%/PROP 20%) 200MG/ML INJECTABLE 1 ML 10 ML 10 MLS 12 ML 15 ML 18 ML 2 ML 20 ML 20 MLS 24 ML 3 ML 30 ML 5 ML 6 ML 8 ML 9 ML; ULTRA-TEST 200 IN SESAME OIL (CYP 80%/PROP 20%) 200MG/ML INJECTABLE 10 ML 30 ML 8 ML; ULTRA-TEST 250 (CYP 80%/PROP 20%) 250MG/ML INJECTABLE 10 ML 20 ML (21 DIFFERENT PRODUCTS)
1193 units, in FDA’s words.
FDA, Drug recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Codes to check against yours
Rx #’s:C0389434 C0389437 C0389439 C0389440 C0389441 C0389442 C0389444 C0389445 C0389446 C0389447 C0389448 C0389449 C0389450 C0389451 C0389452 C0389453 C0389454 C0389455 C0391550 C0397034 C0402354 C0372981 C0377330 C0380467 C0380957…
Every code shown here, 1,996 characters
Rx #’s:C0389434 C0389437 C0389439 C0389440 C0389441 C0389442 C0389444 C0389445 C0389446 C0389447 C0389448 C0389449 C0389450 C0389451 C0389452 C0389453 C0389454 C0389455 C0391550 C0397034 C0402354 C0372981 C0377330 C0380467 C0380957 C0381304 C0382133 C0383978 C0384095 C0385948 C0385973 C0385977 C0385980 C0386103 C0387091 C0387437 C0387546 C0387549 C0387587 C0387588 C0387589 C0387733 C0387734 C0387736 C0387738 C0387753 C0388095 C0388096 C0388097 C0388098 C0388099 C0388100 C0388101 C0388107 C0388208 C0388209 C0388211 C0388212 C0388216 C0388217 C0388247 C0388248 C0388341 C0388349 C0388379 C0388875 C0388877 C0388878 C0388879 C0388881 C0388948 C0388950 C0388951 C0388952 C0388954 C0388956 C0388959 C0388961 C0388964 C0388965 C0388967 C0388968 C0388969 C0388970 C0388971 C0388972 C0388973 C0388975 C0388976 C0388977 C0388978 C0388979 C0388982 C0388984 C0388986 C0388987 C0388990 C0388994 C0388997 C0388998 C0389000 C0389002 C0389003 C0389005 C0389007 C0389008 C0389010 C0389011 C0389013 C0389014 C0389016 C0389018 C0389019 C0389020 C0389021 C0389024 C0389028 C0389413 C0389415 C0389685 C0389738 C0389822 C0389917 C0389918 C0389919 C0389921 C0389923 C0389925 C0389927 C0389929 C0389931 C0389932 C0389933 C0389935 C0389937 C0389938 C0389939 C0389940 C0389942 C0389943 C0389945 C0389958 C0389959 C0389960 C0389961 C0389962 C0389964 C0389966 C0389969 C0389970 C0389971 C0389980 C0389990 C0390034 C0390035 C0390257 C0390258 C0390259 C0390263 C0390266 C0390268 C0390270 C0390274 C0390281 C0390283 C0390287 C0390290 C0390378 C0390381 C0390386 C0390432 C0390435 C0390436 C0390437 C0390438 C0390439 C0390440 C0390441 C0390442 C0390443 C0390444 C0390446 C0390447 C0390448 C0390449 C0390450 C0390451 C0390452 C0390453 C0390454 C0390666 C0390667 C0390669 C0390670 C0390683 C0390685 C0390687 C0390688 C0390690 C0390691 C0390694 C0390696 C0390698 C0390699 C0390701 C0390707 C0390711 C0390712 C0390750 C0390752 C0390753 C0390756 C0390758 C0390759 C0390760 C0390762 C0390767 C0390769 C0390778 C0390780 C0390785…
FDA’s list runs to 10,410 characters. The first part is shown; the rest is on FDA’s record.
Copied exactly as FDA lists them: lot and serial numbers, dates and other codes on the product or its label.
Where did it go?
FDA’s words for the “general area of initial distribution”: where the firm first shipped it.
Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies
These words name no state.
What FDA means by nationwide
“The term “nationwide” is defined to mean the fifty states or a significant portion. Note that subsequent distribution by the consignees to other parties may not be included.”
openFDA, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
Is it still going on?
Terminated, in FDA’s file.
“FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.”
openFDA, on “Terminated”, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
- The firm began the recall on May 21, 2012.
- FDA classified it on Aug 10, 2012.
- FDA’s Enforcement Report published it on Aug 22, 2012.
- FDA terminated it on Aug 15, 2014.
FDA, Drug recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Who is recalling it?
- Franck’s Lab Inc., d.b.a. Franck’s Compounding Lab, of Ocala, FL.
- Who began it, in FDA’s words: Voluntary: Firm initiated.
- How the firm first told its customers: Letter.
FDA, Drug recall enforcement reports. Released Oct 14, 2026. Updated weekly.
What this record can’t tell you
- Whether your own one is affected: compare the codes, dates and numbers above with yours. When unsure, ask the firm or the store.
- Where it went after the firm’s first shipments. FDA’s words cover the firm’s initial distribution, and, in FDA’s words, “subsequent distribution by the consignees to other parties may not be included.”
- How many have been returned, corrected or destroyed: FDA’s report doesn’t say.
- Whether anyone was hurt or fell ill: the report doesn’t say.
- How current it is: openFDA publishes FDA’s Enforcement Report weekly, after FDA does, and a firm can announce a recall weeks before it appears there. openFDA’s own caution: “This data should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall.”
- FDA’s list of codes runs to 10,410 characters; the first part is shown here, and the rest is on FDA’s record.
- A product with no recall here isn’t safe by that: FDA’s report lists the recalls FDA classified, and when.
Hearth Record wrote these lines; the quotations are FDA’s.
Sources
-
U.S. Food and Drug Administration, Drug recall enforcement reports.
Released Oct 14, 2026 and checked Oct 20, 2026. Updated weekly. Public domain (CC0 1.0, openFDA). FDA asks that nothing suggest it endorses this site.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.” Copied on Oct 20, 2026.